Strata Critical Medical, Inc.
SRTANASDAQIndustrials● Active
$5.79
$-0.47(-7.51%)
Market Cap$500988840
P/E Ratio—
52W High$6.5
52W Low$3.51
Strata Critical Medical, Inc. (SRTA) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SRTA · as of 2026-06-08
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-09 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.04B | ($0.03B) | ($0.06B) | ($0.03B) | ($0.04B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.02B | $0.02B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | ($0.01B) | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Net Cash from Operations | ($0.05B) | ($0.00B) | ($0.03B) | ($0.04B) | ($0.02B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.03B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.15B) | ($0.14B) | ($0.27B) | ($0.23B) | ($0.31B) |
| Sales of Investments | $0.30B | $0.18B | $0.29B | $0.36B | $0.01B |
| Net Cash from Investing | $0.07B | ($0.00B) | $0.02B | $0.08B | ($0.32B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Cash from Financing | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) | $0.33B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.06B) | ($0.04B) | ($0.03B) | ($0.04B) | ($0.02B) |
| FCF Margin %(computed) | -30.40% | -14.28% | -15.30% | -25.91% | -32.49% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Strata Critical Medical, Inc. data
About Strata Critical Medical, Inc. (SRTA) Cash Flow Statement
Strata Critical Medical, Inc. generated operating cash flow of ($0.05B) and free cash flow of ($0.06B) for 2025 — a FCF margin of -30.40%. Capital expenditure was ($0.01B).
Frequently asked questions
SRTA · 4 questionsStrata Critical Medical, Inc. generated free cash flow of ($0.06B) for 2025, down 68.7% year-over-year.
SRTA free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08